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Abstract
Background: Conditional knockout mice and transgenic mice expressing recombinases, reporters, and inducible
transcriptional activators are key for many genetic studies and comprise over 90% of mouse models created.
Conditional knockout mice are generated using labor-intensive methods of homologous recombination in
embryonic stem cells and are available for only ~25% of all mouse genes. Transgenic mice generated by random
genomic insertion approaches pose problems of unreliable expression, and thus there is a need for targeted-
insertion models. Although CRISPR-based strategies were reported to create conditional and targeted-insertion
alleles via one-step delivery of targeting components directly to zygotes, these strategies are quite inefficient.
Results: Here we describe Easi-CRISPR (Efficient additions with ssDNA inserts-CRISPR), a targeting strategy in which
long single-stranded DNA donors are injected with pre-assembled crRNA + tracrRNA + Cas9 ribonucleoprotein
(ctRNP) complexes into mouse zygotes. We show for over a dozen loci that Easi-CRISPR generates correctly
targeted conditional and insertion alleles in 8.5–100% of the resulting live offspring.
Conclusions: Easi-CRISPR solves the major problem of animal genome engineering, namely the inefficiency of
targeted DNA cassette insertion. The approach is robust, succeeding for all tested loci. It is versatile, generating
both conditional and targeted insertion alleles. Finally, it is highly efficient, as treating an average of only 50 zygotes
is sufficient to produce a correctly targeted allele in up to 100% of live offspring. Thus, Easi-CRISPR offers a
comprehensive means of building large-scale Cre-LoxP animal resources.
Keywords: CRISPR/Cas9, Homology directed repair, Easi-CRISPR, long ssDNA donors, CRISPR ribonucleoproteins,
Cre-LoxP, Conditional knockout, Reporter and recombinase knock-in
* Correspondence: suzi.mansour@genetics.utah.edu; masato@is.icc.u-
tokai.ac.jp; cgurumurthy@unmc.edu
†Equal contributors
19Department of Human Genetics, University of Utah, Salt Lake City, UT
84112, USA
2Department of Molecular Life Science, Division of Basic Medical Science and
Molecular Medicine, Tokai University School of Medicine, 143 Shimokasuya,
Isehara, Kanagawa 259-1193, Japan
1Mouse Genome Engineering Core Facility, Vice Chancellor for Research
Office, University of Nebraska Medical Center, Omaha, NE, USA
Full list of author information is available at the end of the article
© The Author(s). 2017 Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0
International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and
reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to
the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver
(http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
Quadros et al. Genome Biology  (2017) 18:92 
DOI 10.1186/s13059-017-1220-4
Background
Conditional knockout mouse models, in which one or
more critical coding exons of a gene are flanked by simi-
larly oriented LoxP sites (i.e., floxed), are among the
most useful genetically engineered models in biomedical
research. They provide the opportunity to define essen-
tial gene functions in both global and tissue-specific
contexts [1, 2] and are particularly critical for analyzing
genes that have essential functions early in development.
Indeed, several large-scale global projects pursued under
the umbrella of the International Mouse Phenotyping
Consortium (IMPC) set a collective goal of generating a
floxed or deletion allele for each mouse gene and to
make these alleles readily available to the research com-
munity [3, 4]. To date, this goal has been pursued using
traditional strategies that rely on homologous recombin-
ation (HR) in embryonic stem (ES) cells to deliver
targeting cassettes flanked by long regions of homology
(~3–10 kb) to the gene of interest [5], followed by
appropriate selection techniques. Correctly targeted ES
cells are then introduced into mouse embryos, and the
resulting chimeric mice are used to transfer the floxed
allele to subsequent generations. The time required to
generate floxed mice by the standard method is at least
6 months, even when starting with an ES cell line pro-
cured from one of the repositories. Furthermore, only
about 25% of mouse genes have been targeted in this way,
and the genetic background of ES cells used by the con-
sortium is limited to the C57BL/6 strain, which, though a
reference strain, is not ideal for all purposes [6, 7].
CRISPR/Cas9-directed genome editing should, in the-
ory, allow for the more rapid generation of floxed alleles
in any chosen genetic background, because the editing
components can be delivered directly to single-cell mouse
zygotes of any strain. Indeed, within months of the first
demonstration of CRISPR/Cas9 genome editing to pro-
duce small gene disruptions in mammalian cells [8, 9], a
proof-of-concept study showed that conditional knockout
mice could be generated by homology-directed repair
(HDR) following injection of mouse zygotes with five
components: two separate single guide RNAs (sgRNAs)
targeted to sequences flanking an exon of interest; two
single-stranded oligodeoxynucleotide (ssODN) donors,
each containing a LoxP site flanked by short (40–80 bases)
arms homologous to the desired insertion site; and Cas9
mRNA. Using this method, the authors found that Mecp2
was correctly floxed in 16% of the embryos/mice derived
after transfer of injected zygotes [10]. To date, however,
only two other reports have been published showing that
floxed mice can be generated using this approach. Bishop
et al. [11] and Miano et al. [12] reported efficiencies of
LoxP integration of 2–5% and identified some of the rea-
sons for its poor success. A recent news article in Science
reported anecdotal evidence that this method has been
unsuccessful at many loci, and that cases of successful
CRISPR-directed floxing had efficiencies of only 1 or 2%
[13]. A major factor limiting the targeting efficiency of this
approach is the complex set of modifications that the
targeting components can generate in addition to the
desired insertion of two LoxP sites located in cis. These
include single LoxP insertions, double LoxP insertions
located in trans, and a variety of deletions resulting from
non-homologous end-joining (NHEJ), all of which may
vary in a locus-dependent manner [10, 11]. Thus, this ap-
pealingly simple and rapid two-ssODN donor approach is
not robust enough for routine generation of floxed alleles.
As an alternative to short ssODN donors, insertions of
longer sequences (floxed exons or coding sequences) have
been attempted using double-stranded DNA (dsDNA) do-
nors with homology arms of at least 0.5–1 kb. Compared
with ssODN donors, the insertion efficiency of dsDNA
donors is often poor [10, 14–16]. For example, an IMPC
study showed that classic HR-mediated cassette insertion
could be achieved directly in zygotes by creating two nicks
near the target site using Cas9 nickase and co-injecting
a floxed donor cassette of dsDNA with homology arms
of ~1.9 kb [17]. However, only one out of thirteen pups
born contained the desired allele, and this approach has
not been used routinely.
Other strategies for increasing the efficiency of
CRISPR/Cas9 genome editing include inhibition of
NHEJ or enhancement of HDR through chemical treat-
ments [18, 19]. These approaches, however, are based on
perturbation of DNA repair processes and may be toxic
[20]. Additional strategies include the use of circular
donors with built-in artificial guide sequences that are
linearized inside the cell/embryo, wherein donors are
inserted at the genomic Cas9 cleavage site by cellular
ligases [21–23]. These targeting designs include either
micro-homology ends between the cleaved ends of the
genomic DNA and donor DNA, or ssODNs that bind to
the two free ends so that precise fusion occurs between
the donor and genomic DNAs. Although these latter
strategies offer better alternatives to those that perturb
DNA repair, they too have limitations, including low-to-
moderate efficiencies and the need for custom design of
donor plasmids for each target site. Due to the poor
efficiency of direct zygote injections, some groups have
also tried to develop CRISPR/Cas9-based strategies for
creating knock-ins via ES cell targeting [20, 24, 25].
Although these proved feasible, they are neither efficient
nor robust enough for routine application.
Because short ssODN donors are inserted efficiently at
Cas9 cleavage sites through an HDR pathway, we reasoned
that this repair mechanism might be exploited to deliver
longer cargo if the length of the single-stranded DNA
(ssDNA) could be extended. Based on our experience with
using ssDNA donors and an sgRNA to insert ~400-base
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fragments into the mouse genome with high efficiency
when assayed at embryonic stages [26], we asked whether
longer ssDNA donors and two guide RNAs could be used
to generate mice with floxed exons. Here, we demonstrate
that long ssDNA donors with short homology arms
generate conditional knockout mice at high efficiency
when using pre-assembled crRNA + tracrRNA + Cas9
ribonucleoprotein (ctRNP) complexes containing two
guide RNAs. We also show that knock-ins of reporter,
recombinase, and transcriptional effector genes can be
generated at similar efficiencies, by providing long ssDNA
donors with ctRNPs that contain one guide RNA. Our
method, called Easi-CRISPR (Efficient additions with
ssDNA inserts-CRISPR), is robust and, having been tested
at more than a dozen loci (creating seven floxed and six
knock-in alleles), is also highly generalizable. Easi-CRISPR
thus provides a comprehensive solution to the challenges of
generating both necessary components (floxed and Cre al-
leles) for conditional gene ablation in mice, as well as enab-
ling rapid development of numerous other desired alleles.
Results
Efficient generation of floxed alleles using long ssDNA
donors
As a test case, we selected Pitx1 and generated a 1046-
base ssDNA donor containing a floxed version of exon 2,
flanked by 93- and 91-base left and right homology arms,
respectively. Two guide RNAs (sgRNAs) were designed to
cut the genome immediately adjacent to each homology
arm (Additional file 1: Figure S1a). We injected the
ssDNA donor with Cas9 mRNA and the two sgRNAs into
mouse zygotes following standard CRISPR genome engin-
eering protocols [27]. Genotyping of the resulting live off-
spring, using three sets of PCR reactions specific for
targeted insertion of each LoxP site and for the entire
floxed exon, revealed that one out of eight (13%) carried a
correctly floxed allele (Additional file 1: Figure S1b–g).
Three other pups had partial insertions of the donor
cassette: two contained only a single targeted LoxP site
and one contained both LoxP insertions, but they were
located on separate alleles (in trans).
We suspected that the partial insertions might be a re-
sult of using Cas9 mRNA, which must first be translated
to produce Cas9 protein, and that low protein levels
might reduce the probability of simultaneously cleaving
both sites on the same allele. It was demonstrated previ-
ously that ssODN donors promote increased frequencies
of HDR when they are delivered with a ribonucleopro-
tein (RNP) complex comprised of Cas9 protein and
separated guide RNAs (crRNA + tracrRNA) relative to
when they are delivered with Cas9 in complex with
sgRNA or with a mix of Cas9 mRNA with sgRNA [28].
To determine whether a similar approach could enhance
the frequency of HDR with long ssDNA donors, we
prepared a crRNA + tracrRNA + Cas9 protein complex
using chemically synthesized crRNAs and tracrRNAs
designed to cleave Pitx1 in exactly the same sites as the
sgRNAs described above. Hereafter we refer to crRNA +
tracrRNA + Cas9 complexes as ctRNPs to avoid confu-
sion with sgRNA/Cas9 RNP complexes, which are called
sgRNPs. The ctRNP complex was mixed with the same
Pitx1 floxed exon 2 ssDNA donor used previously and
injected into zygotes. Genomic DNA from the result-
ing offspring were genotyped and those with Pitx1 in-
sertions were sequenced. Schematics of the workflow of
Easi-CRISPR with ctRNPs and the details of the Pitx1
donor design and genotyping PCRs are shown in
Fig. 1a–f. We obtained ten live offspring from these
Easi-CRISPR with ctRNP injections. Two animals had
no insertions, four had partial insertions of a single
LoxP site, and four had bona fide floxed alleles (40%
correct insertion; Fig. 1g, h).
Encouraged by this result, we asked whether similarly
high targeting efficiencies could be obtained at other
loci. We selected six more genes (Ambra1, Col12a1,
Ubr5, Syt1, Syt9, and Ppp2r2a) to generate floxed alleles
using Easi-CRISPR with ctRNPs. Details of the target
exons, the lengths of the ssDNA repair templates, hom-
ology arms, and genotyping strategies are shown in Fig. 2
and Additional file 1: Figure S2. The microinjection
details and the efficiencies of precise floxing are shown
in Table 1. Our targeting strategy succeeded for all six
genes, with efficiencies ranging from 8.5 to 100%. Of
note, at least two founder pups contained biallelic inser-
tions of the donor cassettes (Fig. 2h, Col12a1flox #3;
Additional file 1: Figure S2i, Ppp2r2aflox #3; Table 1).
To directly compare Easi-CRISPR with the previ-
ously described method for generating floxed alleles
[10], we targeted the same Pitx1 exon using two guides
and two short ssODN donors containing the LoxP sites
(Additional file 1: Figure S3a). We prepared the Pitx1
ctRNP exactly as described above and injected it, to-
gether with the two ssODN donors, into 66 zygotes,
from which 18 animals were born. Genotyping showed
that many animals carried a single LoxP site (three had
only the 5′ LoxP and three had only the 3′ LoxP). Only
one of the 18 animals contained both LoxP sites on the
same allele (in cis; Additional file 1: Figures S3b, c, lane 2).
However, the sequence of the distal LoxP site contained a
mutation (Additional file 1: Figure S3d), and therefore this
animal would not be useful for conditional deletion of
Pitx1; similar unwanted mutations, in LoxP sites, were
reported previously for another locus [12]. Of note, even
the genomes that had single LoxP insertions also con-
tained various types of deletions (evident by differently
sized PCR products; Additional file 1: Figure S3c, lanes 5,
8, 14, and16). These results clearly confirm that although
various types of insertion events can occur when using the
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two-ssODN donor method, it is quite challenging to
identify and/or obtain correctly targeted animals. These
observations are similar to those made by others [11, 12].
In summary, for all seven genes combined, genotyping
of 46 G0 pups showed that 20 (43%) contained at least
one correctly floxed allele, with an efficiency ranging
from 8.5–100% at different loci. The fidelity of the inser-
tions and correct fusions was confirmed by sequencing
(Additional file 1: Figures S4–S10). Of the 20 founders
with correctly floxed exons, two contained point muta-
tions in the inserted regions (one each for Pitx1 and
Ambra1) that may have derived from enzymatic misin-
corporation during preparation of the ssDNA donor
templates. Nevertheless, such mutations did not affect the
overall goal of generating floxed mice because we obtained
at least one founder with a correct insertion for each gene.
Moreover, even the founders with mutations are potentially
useful because the mutations were located in intronic sites
that are less likely to affect gene function.
Efficient generation of knock-in alleles using long ssDNA
donors
Based on the success of Easi-CRISPR for floxing various
loci, we asked whether similar efficiencies could be ob-
tained for knock-ins of sequences that encode reporters,
recombinases, and transcriptional regulators. We designed
a
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and Cas9 protein. Combining them generates a ctRNP complex. The term ctRNP used here was formerly known as a cloning-free CRISPR/Cas9 system
[28]. b A long ssDNA donor derived from a floxed exon cassette (or knock-in cassette as in Fig. 3) is mixed with ctRNP(s) to obtain the final Easi-CRISPR
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Quadros et al. Genome Biology  (2017) 18:92 Page 4 of 15
ssDNA donors and the appropriate guide RNAs to target
six different loci. The ssDNA donor cassettes consisted of
sequences ranging from 0.8–1.4 kb, and encoded either
FlpO recombinase, the reverse tetracycline transactivator
(rtTA), or the reporters mCherry and mCitrine (Table 2).
As with the donors designed for floxing, these inserts were
flanked by homology arms of 60–105 bases. Schematics of
the ssDNA cassettes, lengths of homology arms, and
knock-in cassettes are shown in Fig. 3a, b and Additional
file 1: Figures S11a–S15a and their full sequences are
shown in Additional file 1: Figures S16–S21. PCR geno-
typing of offspring indicated that targeted insertion effi-
ciencies for the different genes ranged from 25–67%
(Fig. 3c; Additional file 1: Figures S11b–S15b; Table 2).
Correct targeting was confirmed by sequencing the ex-
pected 5′ and 3′ junction fragments (Fig. 3d; Additional
file 1: Figures S11c–S15c). Of the 39 pups analyzed, 17
(44%) had the expected sequence at both junctions.
Although three more pups contained targeted insertions,
they were not perfect at their 3′ junctions; two of the
pups contained extra sequences (e.g., Slc26a5P2A-FlpO #1
(Additional file 1: Figure S11b) and Mmp9T2A-mCitrine #10
(Additional file 1: Figure S14b)), and the third pup lacked
some of the donor sequence (e.g., Mmp13T2A-mCherry #2
(Additional file 1: Figure S15b)). Of note, one founder for
Fgf8P2A-FlpO contained biallelic insertions of the knock-in
cassette (Fig. 3c). The sequences of the inserts were accur-
ate in 12 of the 17 founders. The remaining five animals
(one each for Fgf8, Slc26a5, Mafb, Mmp9, and Mmp13
founders) contained point mutations in their knock-in
cassettes that may have derived from enzymatic misincor-
poration during preparation of ssDNA donor templates.
Easi-CRISPR was repeated for Fgf8P2A-FlpO because only
one knock-in founder was initially produced and it con-
tained a non-synonymous mutation in the FlpO cassette.
Similarly, only one knock-in OtoartTA founder was born
and it was a runt that did not survive past 5 weeks of age.
The second batch of experiments resulted in two out of
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Fig. 2 Generation of floxed alleles for Ambra1, Col12a1, and Ubr5 using Easi-CRISPR. a–c The wild-type alleles, floxing ssDNA donors for targeting exons
4, 2, and 58 of Ambra1, Col12a1, and Ubr5, respectively, and the corresponding floxed alleles. The lengths of ssDNA, homology arms, and the distance
between the two LoxP sites are shown. d–f The primer pairs and genotyping PCRs are indicated as in Fig. 1f. The floxed allele schematics show minor
differences in primer locations for each gene with respect to target exon size and location. g–i Genotyping of G0 offspring. The expected sizes of PCR
amplicons (wild type or floxed) are indicated to the left of the gels. j–l Genotype interpretations are summarized below the gel images (M monoallelic,
B biallelic, N no insertion). j Interpretation of Ambra1 genotyping: animals 1, 2, 3, 5, 7, and 8 had both the 5′ and 3′ LoxP sites located in cis. Note that
animals 4 and 6 also contain additional amplicons smaller than the expected size (shown by arrows), suggesting that they harbor deletions and/or
are mosaic. The sequences of the deletion alleles were not determined. Animals 1 and 5 were bred to wild type and a CD4 Cre mouse line (Fig. 5;
Additional file 1: Figure S4). k Interpretation of Col12a1 genotyping: animals 1 and 2 were heterozygous for both 5′ and 3′ LoxP sites located in cis, and
they carried deletions in their second allele (shown by the arrows); animal 3 was biallelic for both the 5′ and 3′ LoxP sites. The lanes between the marker
and the samples in the full-length PCR gel image (bottom panel) were cropped out because they belonged to another experiment. l Interpretation of
Ubr5 genotyping: animals 1 and 2 were heterozygous for both 5′ and 3′ LoxP sites located in cis
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six Fgf8P2A-FlpO and three out of eight OtoartTA live-
born animals carrying the desired knock-in (Additional
file 1: Figure S22). The efficiencies of knock-ins were
comparable between the two independent sessions of
microinjections—25 versus 33% for Fgf8P2A-FlpO and 50
versus 37.5% for OtoartTA—demonstrating the reprodu-
cibility of our method.
Easi-CRISPR founders transmit their modified alleles to
offspring, which show the expected phenotypes
Founders from each of the 13 Easi-CRISPR targeting
experiments were bred to wild type mice to transmit
the mutant alleles. To date, five of the conditional
and four of the knock-in alleles have produced off-
spring that carry the targeted alleles (Fig. 4;
Table 1 Microinjection data for floxed allele generation at seven loci
Gene-insertion cassette ssDNA length Left Arm-
Cassette-Right Arm (bases)
[source of ssDNA]
Zygotes
injected
Zygotes
transferred
Live-born animals
(percentage of
transferred zygotes)
Targeted
animals (%)a
Pitx1-exon 2 floxed 93 + 862 + 91
[IvTRT]
85 76 10 (13.2) 4 (40%)b
Ambra1-exon 4 floxed 96 + 589 + 103
[IvTRT]
67 63 8 (12.7) 6 (75%)c
Col12a1-exon 2 floxed 55 + 527 + 55
[IvTRT]
105 79 3 (3.8) 3 (100%)d
Ubr5-exon 58 floxed 78 + 535 + 86
[IvTRT]
20 16 2 (12.1) 2 (100%)e
Syt1-exon 6 floxed 75 + 635 + 75
[IDT Megamer™]
51 45 8 (17.8) 1 (12.5%)f
Syt9-exon 3 floxed 87 + 893 + 68
[IDT Megamer™]
43 41 12 (29.3) 1 (8.5%)g
PPP2r2a-exon 3 floxed 95 + 619 + 84
[IDT Megamer™]
34 33 3 (9.1) 3 (100%)h
aThe alleles that did not contain the inserts were not analyzed for the presence of indels because genotyping assays were mainly designed to identify the targeted-
insertion alleles. However, noticeable deletions were observed for some samples (e.g., deletions in the non-targeted alleles; Fig. 2g, h; Additional file 1: Figure S2i)
bAnimals 3, 5, 7, and 8 were heterozygous for both 5′ and 3′ LoxP sites. Animal 5 had a floxed allele with one nucleotide insertion mutation at the intronic region,
which may not affect function. Animals 2, 9, and 10 had only 5′ LoxP site, and animal 4 had only 3′ LoxP site (Fig. 1g)
cAnimals 1, 2, 3, 5, 7, and 8 were heterozygous for both the 5′ and 3′ LoxP sites (Fig. 2g). Animal 7 had a floxed allele with 1-bp insertion mutation in the intronic
region, which may not affect function
dAnimals 1 and 2 were heterozygous for both 5′ and 3′ LoxP sites and they carried deletions in their second allele. Animal 3 was biallelic for both LoxP sites (Fig. 2h)
eAnimals 1 and 2 were heterozygous for both 5′ and 3′ LoxP sites (Fig. 2i)
fAnimals 4 and 7 had only 5′ LoxP insertion and the animal 6 had correctly targeted LoxP sites (Additional file 1: Figure S2g)
gAnimal 12 had correctly targeted LoxP sites and all others were wild type (Additional file 1: Figure S2h).
hAnimals 1 and 2 were heterozygous for both loxPs with deletions in the second allele and pup 3 was biallelic (Additional file 1: Figure S2i)
Table 2 Microinjection data for knock-in allele generation at six loci
Gene-insertion cassette ssDNA length Left Arm-
Cassette-Right Arm (bases)
[source of ssDNA]
Zygotes
injected
Zygotes
transferred
Live-born animals
(percentage of
transferred zygotes)
Targeted
animals (%)a
Fgf8-P2A-FlpO 105 + 1368 + 98
[IDT Megamer™]
22 13 4 (30.8) 1 (25%)b
Slc26a5-P2A-FlpO 99 + 1368 + 72
[IDT Megamer™]
28 22 3 (13.6) 1 (33%)c
Mafb-P2A-FlpO 85 + 1368 + 96
[IDT Megamer™]
58 53 8 (15.1) 2 (25%)
Otoa-rtTA 96 + 1220 + 98
[IDT Megamer™]
19 18 2 (11.1) 1 (50%)
Mmp9-T2A-mCitrine 60 + 782 + 60
[IvTRT]
52 50 12 (24) 8 (67%)d
Mmp13-T2A-mCherry 60 + 779 + 60
[IvTRT]
55 52 10 (19.2) 4 (40%)
aThe alleles that did not contain the inserts were not analyzed for the presence of indels because genotyping assays were mainly designed to identify the
targeted-insertion alleles. However, noticeable sequence additions or deletions were observed for some samples in these assays (e.g., additions in Slc26a5 animal
1 (Additional file 1: Figure S11), in Mmp9 animal 10 (Additional file 1: Figure S14), and deletion in Mmp9 animal 4 (Additional file 1: Figure S14))
bAnimal 4 had bi-allelic insertions of the knock-in cassette (Fig. 3c)
cAnimal 1 had additional sequences at the 3′ junction (sequence not fully characterized and pup 3 had a precise insertion at both junctions (Additional file 1: Figure S11)
dAnimal 4 appeared to be mosaic containing both a correctly targeted allele and a deletion in the 3′ junction (sequence not fully characterized) (Additional file 1: Figure S14)
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bLeft Arm
105 bases
Last coding Exon TAG
Right Arm
98 bases
1571 bases
1368 bases
Wild Type Allele
ssDNA Donor P2A-FlpO
Fgf8 5’ F FlpO 5’ R Fgf8 3’ RFlpO 3’ F
Last coding Exon TAGP2A-FlpO
wt 1   2   3   4  M
5’ junction PCR (434bp) 3’ Junction PCR (283bp) 
wt 1   2   3   4  M
GCCCCGGAGCCCCGA TAGGCGCTCGCCCAGCTCCTCCCCAd
guide RNA cut site
Fgf8 left arm   P2A-FlpO P2A-FlpO  Fgf8 right arm 
Mutant: 1749bp
Wild Type: 380bp
Flanking primer PCR 
M wt 4   kb
Knock-in allele
Left 
Arm
Right
Arm
Knock-in cassette
New sequence
Genomic Locus
Knock-in
ssDNA donor
Target                     site  
Recombinase/Reporter
ctRNP
a
Knock-in alleles design of  Easi-CRISPR
Injection components
1. Knock-in ssDNA donor
2. One ctRNP
Recombinase/ Reporter
Genotyping Sequencing
ck-i  sette
c
Fig. 3 Fusion of P2A-FlpO to the 3′ end of Fgf8 using Easi-CRISPR. a How Easi-CRISPR is used to generate knock-in alleles. b The Fgf8 locus, ssDNA
donor, and the resulting targeted insertion allele. c Genotyping of G0 offspring. Primer locations for 5′ and 3′ junction PCRs are shown, along with
expected amplicon sizes. Founder 4 has a correctly targeted P2A-FlpO insertion, as indicated by the presence and size of both 5′ and 3′ junction
amplicons. The gel on the right shows that PCR amplification of this founder’s DNA with primers flanking the Fgf8 insertion site produced only the
mutant amplicon, indicating that it is a biallelic insertion. WT wild type, M 100-bp marker; kb 1-kb marker. d Sequencing of 5′ and 3′ junctions in
founder 4. The guide RNA sequence (italics), along with the cut site, PAM sequence (in red), a few bases of flanking sequences (above) and sequence
chromatograms showing correctly targeted 5′ and 3′ junctions are shown below
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Additional file 1: Figure S2j–l). Of note, the biallelic
founders that were bred transmitted the targeted
mutation, as expected, to all offspring in their litters
(Fig. 4c, Fgf8P2A-FlpO; Additional file 1: Figure S2l,
Ppp2r2aflox). To determine whether the conditional
alleles could be deleted using a tissue-specific Cre,
we bred Ambra1 founders to a CD4 Cre driver line
[29]. Genomic DNA isolated from the peripheral
blood of floxed heterozygote and Cre-positive off-
spring showed the expected recombination pattern
(Fig. 5a, b). Similarly, to determine whether the
knock-in alleles express as desired, one Fgf8P2A-FlpO
founder and one Slc26a5P2A-FlpO F1 were bred to a FlpO
reporter line [30] and the offspring were analyzed for
expression of tdTomato. As expected, the offspring of
these two animals showed appropriate expression of the
inserted sequence (Fgf8P2A-FlpO #4 drove expression in
cochlear inner hair cells; Fig. 5c). These results indicate
that Easi-CRISPR can efficiently insert sequences that
encode and express reporters, recombinases, and regula-
tory proteins, and that the technique is applicable to
multiple genomic loci.
Discussion
Development of a high efficiency method for creating
conditional and insertion alleles
Even though the CRISPR system has led to many para-
digm shifts in animal transgenesis [31–33] and is routinely
used to generate mice with small insertions and deletions,
until now there have been no simple strategies for efficient
and targeted insertion of long sequences via direct zygote
microinjection of CRISPR components. There has been an
intensive effort made by the community during the past
3 years to use CRISPR-based strategies for developing
floxed models through zygote injections [11, 12, 17], and
also through ES cell targeting strategies [20, 24, 25]. The
primary objective of this work was to develop a CRISPR
targeting strategy suitable for both high- and low-
throughput generation of floxed animal models. The
criteria we set for the new strategy were that it should be:
(1) easy to design and build floxed-donor DNA cassettes,
(2) compatible with zygote injections, (3) very efficient,
and (4) generalizable to many loci.
To this end, we extended our previous finding that ~400-
base ssDNAs serve as efficient donors for HDR at single
Ambra1
Fgf8 founder #4 offspring
Fgf8 5’ PCR: 438bp
wt 1    2    3     4    5    6    7    8     9   10   M M    wt 1      2      3      4      5      6      7
Slc26a5 5’ PCR: 324bp
Slc26a5 founder #3 offspring
1      2       3      4       5      6      N     M
Mmp9 founder #3 offspring
Mmp9 5’PCR: 561bp
Founder #5
offspring
1   2   3   4    5   6   1   2   3   4 5   6 M
Founder #1
offspring
F
ou
nd
er
 #
1
w
t
5’ LoxP PCR:
838 bp
3’ LoxP PCR: 
852 bp
5’ LoxP PCR:
1216bp
Founder #8
offspring
1   2   3    4    5   6   N   M
Founder #3
offspring
M  1    2    3    4
3’ LoxP PCR: 
1222 bp
Pitx1
1     2     3    M
Mmp13 founder #3 offspring
Mmp13 5’PCR: 556bp
b
d
a
c
fe
Fig. 4 Germ line transmission of founder alleles generated using Easi-CRISPR. a–f Genotyping of offspring from two founders each for the
Pitx1 and Ambra1 conditional alleles (a, b) and one founder each of the Fgf8, Slc26a5, Mmp9, and Mmp13 knock-in alleles (c–f) showing
germ line transmission from all of these founders. As expected, all the pups from the Fgf8 founder contain a targeted allele because the
founder is biallelic (c)
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Cas9 cleavage sites [26], by first showing that long ssDNA
donors with short homology arms can be used to re-
place a gene segment between two Cas9 cleavage sites,
a critical technical necessity for generating floxed al-
leles. Given the multitude of potential undesired prod-
ucts that are possible from the NHEJ repair pathway
acting at two Cas9 cleavage sites, the high frequency of
recovering correctly floxed alleles at seven different loci
by using Easi-CRISPR (8.5–100%) was surprising, as
previously described strategies reached a maximum of
16% efficiency [10, 11]. Of note, a floxed allele for
Col12a1, one of the loci targeted here by Easi-CRISPR,
was recently developed by using a strategy called PITCh
(Precise Integration into Target Chromosome) [34].
The targeting of Col12a1 by PITCh used the same set
of ctRNP complexes that were used in Easi-CRISPR
(described above) but the difference between the two
methods was in the donor DNA format, unlike the
ssDNA donor used in Easi-CRISPR, the PITCh system
used a dsDNA donor. The PITCh approach required
265 zygotes whereas Easi-CRISPR used only 105 zy-
gotes, and the PITCh approach produced 33% correctly
targeted pups, whereas Easi-CRISPR (using ssDNA
donors) produced 100% correctly targeted pups. Of
Ambra1 flox + +        +       + -
5’ F + 3’ R PCR:
Floxed: 1059bp
Wild Type: 991bp
Deletion allele: 504 bp
CD4 Cre + +        +       - - M   
Genotype
a
CCAGTAGACACCAGCAATGAAGG CCACTTTGTTAGGACTGGTAGAC
c
Left guide Right guide
LoxP---Intron 3---Exon 4---Intron 4---LoxP
Intron 3 Intron 4One LoxP site retained after Cre recombination
b
Fig. 5 Easi-CRISPR alleles perform as intended. Conditional alleles show the expected pattern of Cre-mediated deletion. a Genotyping of lymphocyte
DNA isolated from a litter produced by mating the Ambra1 floxed founder 1 (Fig. 2g, lane 1) with a CD4 Cre strain. Offspring carrying both the floxed
and Cre alleles (first three lanes) show the expected PCR amplicons. wt wild-type control sample, M 100-base pair marker. b Sequencing of a deletion
allele showing Cre recombination (see Additional file 1: Figure S5 for comparing this sequence with the floxed allele sequence). c FGF8-
P2A-FlpO activates a FLP-dependent tdTomato reporter in inner hair cells. A surface preparation of the cochlear epithelium isolated from
a P1-P2 Fgf8P2A-FlpO/+;Rosa26RC::RFLG/+ animal was stained with Alexa488-phalloidin (green). Native tdTomato fluorescence (red) is evident in most inner
hair cells (i), but not in outer hair cells (o)
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note, the PITCh experiment included the Exo1 nuclease,
an enhancer of targeted insertion [34]. In its absence, the
efficiency would likely have been lower than 33%.
While developing our method, an IMPC study investi-
gated whether floxed gene-targeting vectors that had
already been created for ES cell targeting could be modi-
fied and used as dsDNA donors for zygote injections
[35]. Although this study showed the feasibility of the
approach for one gene (six targeted out of 17 live born,
35% efficiency; or one targeted out of two live born, 50%
efficiency), when the same strategy was applied to two
other genes, only one of the two genes yielded a floxed
allele (one targeted out of nine pups for one gene, and
zero out of nine pups for the second gene: 11 and 0%
efficiency, respectively). In comparison, Easi-CRISPR of-
fers better options for several reasons. First, the complex
gene-targeting vectors must be modified in the IMPC
approach before they can be used for zygote injections,
whereas Easi-CRISPR donor designs are simple and
cassettes can be synthesized rapidly by commercial
custom gene synthesis services. Second, the efficiency
of the IMPC method is lower for creating conditional
alleles (0 to 50%), compared to Easi-CRISPR, which has
an efficiency of 8.5–100%.
In addition to floxed alleles, knock-ins of coding se-
quences for recombinases and reporter genes are also
critical tools for Cre-LoxP-based mouse molecular
genetics, and they serve many additional purposes in
biomedical research. Furthermore, in some studies, gene
expression or site-specific recombination is achieved by
using inducible systems, such as those involving the
tetracycline-induced transactivators and repressors [36].
By successfully targeting insertions to six loci we demon-
strate that Easi-CRISPR is suitable for generating all
such knock-in models. Therefore, Easi-CRISPR offers a
comprehensive solution to the Cre-LoxP mouse genet-
ics system because it also allows creation of reporter/
recombinase/transcriptional effector knock-ins, not just
conditional alleles.
Some potential limitations of our method are: (1)
Targeting single exon genes or genes containing unusually
repetitive sequences. This limitation, however, is applic-
able to any gene targeting approach. (2) Targeting in-
sertions longer than 2 kb. Although many types of
commonly used mouse models such as floxed, Cre-, rtTA-,
and reporter- knock-in alleles can be created using ssDNA
donors of 1 to 2 kb long, expanding the synthesis capability
of donors to several kilobases long would enable creation of
a wider range of animal models. This will require technical
improvements that extend the lengths of ssDNA do-
nors. (3) Variability of cleavage efficiencies of guides
(discussed below) can influence insertion efficiencies at
different loci. This issue is inherent to any CRISPR-
based targeting approach. We are confident that future
advances to, or further modifications of, Easi-CRISPR
will address such potential limitations.
Easi-CRISPR is highly robust and generalizable
Easi-CRISPR is robust because one or more correctly
targeted animals can be generated by injecting as few
as 50 zygotes per gene-targeting project (13 targeting
projects were completed using 639 zygotes). The
method is also highly generalizable because it has
worked for over a dozen loci. We noted a wide range
in the frequency of insertions for different loci (8.5–
100%). There are several possible explanations for this
finding. First, we think that a major factor contribut-
ing to the differences in insertion frequencies may
arise from the differences in cleavage efficiency of
guides. A recent report described a systematic analysis
of guide features and identified the parameters that
contribute to variability in cleavage efficiency. They
found that cleavage depended on many factors, includ-
ing nucleotide sequences at both PAM-distal and
PAM-proximal regions of the sgRNA, the genomic
context of the targeted DNA, the GC percentage, and
the secondary structure of sgRNA [37, 38]. It is
possible, therefore, that some guides may not work
and trying alternative guides for those loci may be ne-
cessary [39]. Finding a suitable, high efficiency, guide
can be a critical factor for targeting experiments in
which insertion of a fusion cassette at a specific codon
in the genome is required and good guides are not
available for the target site. In contrast, guide location
is not a major factor in designs for floxed alleles
because the position of LoxP sites in introns is flexible.
For successful floxing, however, both guides need to
be equally efficient at directing cleavage; if one site is
cleaved less efficiently than the other, the overall
targeting efficiency may be lower. This situation may
have occurred with our Pitx1 and Syt1 targeting in
which only one of the two LoxP sites was inserted in
some animals (40% of Pitx1 founders; 25% of Syt1
founders). We suggest that these partial insertions oc-
curred because the second guide may not have cleaved
the genome in those zygotes. A second explanation for
the variability in insertion efficiencies may be differ-
ences in the genomic loci themselves. It was proposed
previously that HDR varies widely from locus to locus
[40–42]. A third explanation could be the inherent
variability in the experimental steps of animal trans-
genesis, such as embryo isolation and ex vivo handling
for microinjection, variability in the embryo transfer
procedure after microinjection, etc. Despite these
potential limitations, the method presented here effi-
ciently generates at least one correctly targeted animal
for each locus and, frequently, most of the animals
born contain the targeted allele.
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Easi-CRISPR will be simple to adapt for both low-
throughput and high-throughput labs
Microinjection of mouse zygotes is a standard tech-
nique and with the exception of one locus (Col12a1;
3.8%), the birth rates of Easi-CRISPR manipulated
zygotes were 9–31%, which is similar to that observed
with conventional pronuclear injections [43]. Although
these birth rates may seem low for some loci, trans-
genic experiments involve many complicated steps,
variation in which affects birth rates. These include the
quality of microinjection reagents, the many steps of
assisted reproduction, animal husbandry conditions,
and, finally, the mothering ability of the recipient fe-
males. Very importantly, the proficiency of technicians
involved can be another major factor. For example, the
extent of trauma caused to the embryos by the volume
of liquid injected and the success of embryo transfers
to the oviducts can vary from technician to technician.
Consequently, most transgenic core labs that rely on
currently available HDR strategies typically inject about
200–300 or more zygotes to generate knock-in models.
Even so, in many cases, these projects are unsuccessful.
Despite the factors discussed above, Easi-CRISPR
clearly stands out as we have thus far successfully
created founders for 13 loci by injecting only 639
zygotes. The majority of these Easi-CRISPR targeting
projects were completed by injecting only about 40–60
zygotes. Of note, the founders for these alleles were
created at three independent facilities by different
technical staff and all projects were successful. Thus,
Easi-CRISPR should be easily adaptable to most low-
and high-throughput applications.
Mechanistic thoughts about the high efficiency of
Easi-CRISPR
Our results suggest that long ssDNAs are key to achiev-
ing high HDR efficiency in CRISPR genome editing. The
other most significant factor contributing to the high
efficiency of Easi-CRISPR could be the ctRNP delivery
of the targeting components. Our experiment directly
comparing Cas9-mRNA/sgRNA injection versus ctRNP
(crRNA + tracrRNA + Cas9 protein) for floxing Pitx1
showed that ctRNP delivery was about three-fold more
efficient than when all components were delivered as
RNA. A similar observation was reported by Aida et al.
[28], who compared the sgRNA/Cas9 mRNA, sgRNP,
and ctRNP platforms programmed with dsDNA donors
and concluded that ctRNP (referred to as cloning-free
CRISPR/Cas) was the most efficient. A recent study of
sgRNP electroporation also indicates its superior perform-
ance over sgRNA/mRNA delivery [44]. Taken together, we
conclude that crRNA + tracrRNA (instead of sgRNA),
Cas9 protein (instead of Cas9 mRNA), and long ssDNA
donors (instead of dsDNAs) are central to obtaining
consistently higher success in CRISPR animal genome
engineering. The high efficiency of Easi-CRISPR could
also be combined with electroporation-based delivery
methods such as GONAD [45, 46], TAKE [47], and
SLENDR [48] to generate floxed or knock-in mice.
The unexpected observation that long ssDNA donors
drive high insertion efficiencies leads to the question of
why there is such a large difference between the target-
ing efficiencies of ssDNA versus dsDNA donors. Among
different HDR types, classic homologous recombination
(HR) uses dsDNA as a donor, while some recently iden-
tified processes, including single strand annealing (SSA)
[49] or micro-homology mediated end joining (MMEJ;
also known as Alt-EJ) [50], rely on the availability of
annealable-partner sequences within the non-recessed
ends themselves. Considering the properties of our
donors, we speculate that the proteins responsible for
either SSA or MMEJ may be involved in ssDNA donor-
mediated repair. Of these two, MMEJ factors are less
likely because this mechanism relies on very short hom-
ologies [50, 51]; whereas SSA operates with arms typic-
ally longer than 30 bases (the arms in our ssDNA
donors are 55–105 bases) [49]. It was recently proposed
that the MMEJ mechanism applies when the donors for
CRISPR editing contain 5–25 base homology arms, al-
though the protein factors involved in this repair process
need to be validated. Many protein factors involved in
various types of HDR pathways have been characterized
[49, 51, 52] and a systematic analysis of Easi-CRISPR
frequencies, in the absence of some of those factors in
mouse embryos, will help delineate the molecular
mechanisms involved.
Other potential applications of Easi-CRISPR
Our results suggest that it is possible to create gene-
replacement models, as demonstrated by our finding that
two cleavages can be used to take out a target exon and
replace it with a floxed exon cassette. Thus, Easi-CRISPR
will also be suitable for generating other types of DNA
replacements, such as (1) a set of point mutations spread
across a region (e.g., up to 1–2 kb long that can be effi-
ciently inserted), (2) testing regulatory sequences, and (3)
replacing short stretches of gene segments or coding
sequences from other species (e.g., creating humanized
mice). In addition, Easi-CRISPR could be used to modify
existing knock-in alleles, for example, by inserting an frt-
stop-frt cassette into an existing lox-stop-lox-controlled
gene to enable dual recombinase control of that gene
without having to start from a wild-type allele.
Because of the availability of numerous genome engin-
eering tools developed during the past four decades, the
mouse has become the main species used to model
human genetic pathophysiology. However, there are
many cases in which mouse models do not recapitulate
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human disease and other species are preferred. Easi-
CRISPR, with its simple design requirements and high
efficiency, may provide the solution to engineering the
genomes of medically relevant laboratory animals as well
as livestock species for which zygote injections can be
performed successfully. For example, there is a particular
need for rat models [53, 54]. The community has begun
exploring CRISPR strategies for generating Cre-LoxP rat
models [15, 55] and many commercial service providers
have initiated rat genome modification services [56]. We
anticipate that because of its numerous benefits, includ-
ing simplicity of design, high efficiency, effectiveness for
many genes, and suitability for both low- and high-
throughput laboratories, Easi-CRISPR will serve as an
effective means of rapidly building mouse Cre-LoxP
resources, and for building similar resources for rat and
other models in the future.
Conclusions
Conditional knockout and transgenic/knock-in models
expressing reporters or recombinases together constitute
over 90% of genetically engineered mouse models
created routinely. Although it was previously claimed
that the CRISPR/Cas9 system could be readily used for
developing such models, it has proven to be highly chal-
lenging because the insertion of foreign DNA cassettes
at Cas9 cleavage sites is inefficient. The Easi-CRISPR
strategy we describe here uses simplified CRISPR tools;
long ssDNA donors and ctRNPs, and allows the inser-
tion of DNA cassettes into genomes with a very high
efficiency. The method has been used at over a dozen
loci revealing robustness, high efficiency and, moreover,
versatility as it can create conditional as well as recom-
binase, reporter, and transcriptional effector knock-in
alleles. The method is also easily adaptable to both low-
and high-throughput genome engineering applications.
Easi-CRISPR therefore solves a major challenge in the
CRISPR animal genome engineering field and offers a
comprehensive system for building large-scale Cre-LoxP
animal resources.
Methods
CRISPR reagents
CRISPR guide RNAs were designed using CRISPR.mit.edu,
or CHOPCHOP, and were used as annealed two-part
synthetic crRNA and tracrRNA molecules for all genes
(Alt-RTM CRISPR guide RNAs, Integrated DNA Technolo-
gies, Inc. (IDT), Coralville, IA, USA and Genome Craft
Type CT, FASMAC, Kanagawa, Japan), and as sgRNAs for
Pitx1. Cas9 mRNA (used for the Pitx1 floxing experiment;
Additional file 1: Figure S1) was prepared using the pBGK
plasmid as described previously [27]. The sgRNAs (used
for the Pitx1 floxing experiment; Additional file 1: Figure
S1) were synthesized as described previously [26]. The
plasmid was linearized with XbaI and used as the template
for in vitro transcription using the mMESSAGE mMA-
CHINE T7 ULTRA kit (Ambion, AM 1345). Recombinant
Cas9 protein employed for RNP injections was the Alt-R™
S.p. Cas9 Nuclease 3NLS (IDT), or from New England Bio-
labs, or FASMAC. dsDNA templates for floxing experi-
ments (containing the homology arms and the floxed exon
sequences) for producing ssDNA donors were custom syn-
thetic genes made by Life Technologies or IDT (for floxing
experiments) and knock-in cassettes were amplified using
long primers to add homology arms. The ssDNA HDR do-
nors were prepared from these cloned dsDNA templates
either using the IvTRT method as described previously
[26] or obtained from IDT (Megamer™ single-stranded
Gene Fragments). Both IvTRT and IDT Megamer™ ssDNA
preps showed comparable HDR efficiencies. Although the
two different versions of ssDNAs have not been tested on
the same genetic locus, we do not anticipate any perform-
ance differences between the two sources (Tables 1 and 2).
Preparation of CRISPR injection mixes
The ctRNP mixes were prepared as follows. Lyophilized
crRNA and tracrRNA (commercially procured) were re-
suspended in microinjection buffer (TrisHCl 10 mM,
pH 7.5, EDTA 0.1 mM). Five micrograms of crRNA
(5 μl of 1 μg/μl) and 10 μg of tracrRNA (10 μl of 1 μg/
μl) were combined in a PCR tube and were annealed in
a thermocycler (95 °C for 5 min followed by ramp down
to 25 °C at 5 °C/min). The annealed crRNA and
tracrRNA (also known as guide RNA) were diluted in
microinjection buffer and mixed with Cas9 protein to
obtain ctRNP complexes [57]. The final concentrations
of components in ctRNP preparations were 5–20 ng/μl
of guide RNA (if two guides were used, each guide was at
5–20 ng/μl) and 5–50 ng/μl of Cas9 protein. The ssDNA
donors were mixed with ctRNP complexes at 5–10 ng/
mix and the final injection mixes were passed through
Millipore Centrifugal Filter units (UFC30VV25, EMD
Millipore, Billerica, MA, USA) and spun at 21,000 g for
5 min at room temperature.
Microinjection of one-cell embryos
All animal experiments performed were approved by the
respective institutional IACUC protocols. C57BL/6 mice at
3–4 weeks of age (Charles River Laboratories, Wilmington,
MA, USA or CLEA, Tokyo, Japan) were superovulated by
intraperitoneal injection of 5 IU pregnant mare serum go-
nadotropin, followed 48 h later by injection of 5 IU human
chorionic gonadotropin (both hormones from National
Hormone & Peptide Program, Torrance, CA, USA). Mouse
zygotes were obtained by mating C57BL/6 stud males with
superovulated C57BL/6 females. One-cell stage fertil-
ized mouse embryos were injected with 5–50 ng/μl
Cas9 protein (or 10 ng/μl of Cas9 mRNA; for Pitx1
Quadros et al. Genome Biology  (2017) 18:92 Page 12 of 15
locus), 5-20 ng/μl of annealed crRNA and tracrRNA (or
10 ng/μl of each sgRNA; for Pitx1 locus) and 5–10 ng/μl
of ssDNA. Microinjections and mouse transgenesis exper-
iments were performed as described previously [27].
Mouse genomic DNA extraction, genotyping, and
sequencing
Mouse genomic DNA was extracted from toe or ear
samples using the Qiagen Gentra Puregene Tissue Kit
(Qiagen Sciences, Maryland, USA) or Allele-In-One
Mouse Tail Direct Lysis Buffer (KURABO, Osaka, Japan).
Primers were designed to amplify the correctly targeted
junctions. Genomic DNA was subjected to flanking pri-
mer PCR and internal (donor oligo-specific) and external
primer PCR. The primer sequences for all 13 genes are
listed in Additional file 1: Table S1. PCR reactions were
performed using the Go Taq Promega Hot Start green
mix (Promega, Madison, WI, USA) or PrimeSTAR HS
DNA Polymerase (TaKaRa, Shiga, Japan). The amplicons
were separated on a 1–3% agarose gel. The gel-purified
amplicons were subjected to sequencing using one of
the PCR primers and/or internal primers. In some cases,
PCR products were cloned into TA (Life Technologies,
catalog number K2020-20) vectors before sequencing.
FlpO activity assay
A homozygous FLP reporter mouse, B6.Cg-Gt(ROSA)26-
Sortm1.3(CAG-tdTomato,-EGFP)Pjen/J (JAX Stock #026932) [30],
was crossed with the Fgf8-P2A-FlpO #4. Whole cochleae
were dissected from P1–P2 pups, cut along Reissner’s
membrane to expose the surface of the sensory epithe-
lium, and fixed overnight at 4 °C in 4% paraformaldehyde
in PBS. The cochleae were stained with Alexa488-
phalloidin (Invitrogen) diluted 1:1500 in PBS containing
0.1% Triton X-100 for 15 min, and then mounted in
Fluoromount-G (SouthernBiotech) on microscope slides.
Cochleae were imaged on an Axioskop (Zeiss) with
epifluorescent illumination and photographed with an
Infinity 3-6UR (Lumenera) digital camera. Green and
red channels were overlaid using Photoshop CS6
(Adobe).
Quantification and statistical analysis
The robustness of the genome-editing method devel-
oped in this work was tested at 13 independent genomic
loci. Each locus-specific experiment was performed by
injecting zygotes to generate founders until at least one
correctly targeted founder animal was obtained. Based
on this criterion, all the 13 loci tried yielded targeted
animals (i.e., 100% success rate). The number of zygotes
injected ranged from 19 to 105 per locus with an average
of 50 zygotes injected per locus to successfully complete a
project (to obtain at least one correctly targeted animal).
The overall efficiency of individual projects was calculated
by the percentage of correctly targeted animals among the
total number of live born animals, which ranged from 8.5
to 100%. The possible reasons of variability across differ-
ent genomic loci are included in the discussion section.
Additional file
Additional file 1: Twenty-two supplementary figures and one
supplementary table. (DOCX 8910 kb)
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